METTL3 and glioblastoma: Li et al. confirmed that m6A methyltransferase METTL3 sustained its oncogenic role by modulating nonsense-mediated mRNA decay (NMD) of serine- and arginine-rich splicing factors (SRSF) and AS isoform switches in GBM [51].